Published in J Biol Chem on January 26, 2007
Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med (2008) 1.52
Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J Clin Microbiol (2007) 1.44
Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol (2009) 1.27
Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems. PLoS Pathog (2011) 0.96
Functional characterization of a newly identified group B Streptococcus pullulanase eliciting antibodies able to prevent alpha-glucans degradation. PLoS One (2008) 0.86
Group B streptococcus pullulanase crystal structures in the context of a novel strategy for vaccine development. J Bacteriol (2009) 0.83
Host and pathogen glycosaminoglycan-binding proteins modulate antimicrobial peptide responses in Drosophila melanogaster. Infect Immun (2010) 0.82
Sequence TTKF ↓ QE defines the site of proteolytic cleavage in Mhp683 protein, a novel glycosaminoglycan and cilium adhesin of Mycoplasma hyopneumoniae. J Biol Chem (2011) 0.81
Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease. Vaccine (2007) 0.80
Surface protein EF3314 contributes to virulence properties of Enterococcus faecalis. Int J Artif Organs (2009) 0.80
Host glycosaminoglycan confers susceptibility to bacterial infection in Drosophila melanogaster. Infect Immun (2008) 0.79
Genomic analysis identifies a transcription-factor binding motif regulating expression of the alpha C protein in Group B Streptococcus. Microb Pathog (2009) 0.78
Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies. Trends Microbiol (2017) 0.77
Survey of immunological features of the alpha-like proteins of Streptococcus agalactiae. Clin Vaccine Immunol (2014) 0.76
Draft Genome Sequence of an Attenuated Streptococcus agalactiae Strain Isolated from the Gut of a Nile Tilapia (Oreochromis niloticus). Genome Announc (2017) 0.75
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc Natl Acad Sci U S A (2005) 14.59
Emerging fungal threats to animal, plant and ecosystem health. Nature (2012) 8.20
Digital disease detection--harnessing the Web for public health surveillance. N Engl J Med (2009) 6.80
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A (2002) 5.28
Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. Lancet Infect Dis (2013) 3.90
Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science (2005) 3.83
Imaging poliovirus entry in live cells. PLoS Biol (2007) 3.40
Global capacity for emerging infectious disease detection. Proc Natl Acad Sci U S A (2010) 3.30
The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes. J Virol (2005) 2.20
Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics (2005) 1.74
Influenza A (H1N1) virus, 2009--online monitoring. N Engl J Med (2009) 1.62
Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease. Emerg Infect Dis (2016) 1.62
Characterization of early steps in the poliovirus infection process: receptor-decorated liposomes induce conversion of the virus to membrane-anchored entry-intermediate particles. J Virol (2006) 1.57
Cryo-electron microscopy reconstruction of a poliovirus-receptor-membrane complex. Nat Struct Mol Biol (2005) 1.53
Picornaviruses. Curr Top Microbiol Immunol (2010) 1.53
Poliovirus RNA is released from the capsid near a twofold symmetry axis. J Virol (2010) 1.51
Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNA-dependent RNA polymerase. J Virol (2007) 1.48
The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer. Mol Cell (2004) 1.44
Catching a virus in the act of RNA release: a novel poliovirus uncoating intermediate characterized by cryo-electron microscopy. J Virol (2010) 1.43
Evaluation of ProMED-mail as an electronic early warning system for emerging animal diseases: 1996 to 2004. J Am Vet Med Assoc (2006) 1.43
Forecasting high-priority infectious disease surveillance regions: a socioeconomic model. Clin Infect Dis (2012) 1.42
Metallic nanohole arrays on fluoropolymer substrates as small label-free real-time bioprobes. Nano Lett (2008) 1.33
An externalized polypeptide partitions between two distinct sites on genome-released poliovirus particles. J Virol (2011) 1.26
Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism. J Biol Chem (2004) 1.22
Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44. J Virol (2004) 1.22
Evaluation of epidemic intelligence systems integrated in the early alerting and reporting project for the detection of A/H5N1 influenza events. PLoS One (2013) 1.22
Upstream short sequence repeats regulate expression of the alpha C protein of group B Streptococcus. Mol Microbiol (2003) 1.21
Structure of the Fab-labeled "breathing" state of native poliovirus. J Virol (2012) 1.16
Crystal structure of the cytomegalovirus DNA polymerase subunit UL44 in complex with the C terminus from the catalytic subunit. Differences in structure and function relative to unliganded UL44. J Biol Chem (2005) 1.16
Cryo-electron microscopy reconstruction shows poliovirus 135S particles poised for membrane interaction and RNA release. J Virol (2013) 1.12
Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit. J Virol (2004) 1.12
RNA transfer from poliovirus 135S particles across membranes is mediated by long umbilical connectors. J Virol (2013) 1.12
The use of immunization registry-based data in vaccine effectiveness studies. Vaccine (2010) 1.11
Timeliness of nongovernmental versus governmental global outbreak communications. Emerg Infect Dis (2012) 1.11
Vaccines to prevent neonatal GBS infection. Semin Neonatol (2002) 1.09
Identification of novel cps locus polymorphisms in nontypable group B Streptococcus. J Med Microbiol (2006) 1.08
Latest outbreak news from ProMED-mail: novel coronavirus -- Middle East. Int J Infect Dis (2012) 1.07
The human cytomegalovirus UL44 C clamp wraps around DNA. Structure (2008) 1.02
Biochemical, biophysical, and mutational analyses of subunit interactions of the human cytomegalovirus nuclear egress complex. J Virol (2009) 1.01
Single particle cryoelectron tomography characterization of the structure and structural variability of poliovirus-receptor-membrane complex at 30 A resolution. J Struct Biol (2007) 1.00
The positively charged surface of herpes simplex virus UL42 mediates DNA binding. J Biol Chem (2008) 0.97
Cholera in United States associated with epidemic in Hispaniola. Emerg Infect Dis (2011) 0.97
Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. J Infect Dis (2002) 0.92
Adherence to, invasion by, and cytokine production in response to serotype VIII group B Streptococci. Infect Immun (2004) 0.92
Cofolding organizes alfalfa mosaic virus RNA and coat protein for replication. Science (2004) 0.92
Rapid actin-dependent viral motility in live cells. Biophys J (2009) 0.92
Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein. Clin Vaccine Immunol (2008) 0.91
Multiple conformations in the ligand-binding site of the yeast nuclear pore-targeting domain of Nup116p. J Biol Chem (2005) 0.91
Binding of herpes simplex virus-1 US11 to specific RNA sequences. Nucleic Acids Res (2005) 0.91
Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines. Infect Immun (2007) 0.90
The two-component response regulator LiaR regulates cell wall stress responses, pili expression and virulence in group B Streptococcus. Microbiology (2013) 0.89
Type IV neonatal early-onset group B streptococcal disease in a United States hospital. J Clin Microbiol (2007) 0.89
Multiplexed plasmonic sensing based on small-dimension nanohole arrays and intensity interrogation. Biosens Bioelectron (2008) 0.85
A 3D framework for understanding enterovirus 71. Nat Struct Mol Biol (2012) 0.85
Group B Streptococcus bacteremia elicits beta C protein-specific IgMand IgG in humans. J Infect Dis (2006) 0.84
Mechanism of action and capsid-stabilizing properties of VHHs with an in vitro antipolioviral activity. J Virol (2014) 0.83
Post-imaging fiducial markers aid in the orientation determination of complexes with mixed or unknown symmetry. J Struct Biol (2008) 0.83
The group B streptococcal alpha C protein binds alpha1beta1-integrin through a novel KTD motif that promotes internalization of GBS within human epithelial cells. Microbiology (2007) 0.83
Crystal structure of the N-terminal domain of the group B streptococcus alpha C protein. J Biol Chem (2005) 0.83
Conformational shift of a major poliovirus antigen confirmed by immuno-cryogenic electron microscopy. J Immunol (2013) 0.82
Lactic acid is a potential virulence factor for group B Streptococcus. Microb Pathog (2008) 0.81
Global Capacity for Emerging Infectious Disease Detection, 1996-2014. Emerg Infect Dis (2016) 0.80
The crystal structure of PF-8, the DNA polymerase accessory subunit from Kaposi's sarcoma-associated herpesvirus. J Virol (2009) 0.80
Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease. Vaccine (2007) 0.80
Host glycosaminoglycan confers susceptibility to bacterial infection in Drosophila melanogaster. Infect Immun (2008) 0.79
Genomic analysis identifies a transcription-factor binding motif regulating expression of the alpha C protein in Group B Streptococcus. Microb Pathog (2009) 0.78
Case records of the Massachusetts General Hospital. Case 20-2011. A 30-year-old man with diarrhea after a trip to the Dominican Republic. N Engl J Med (2011) 0.78
Association of age and comorbidity on 2009 influenza A pandemic H1N1-related intensive care unit stay in Massachusetts. Am J Public Health (2014) 0.75
Immunity to group a streptococcal M proteins: forging a single-edged sword. Clin Infect Dis (2005) 0.75
Seasonal variation in penicillin susceptibility and invasive pneumococcal disease. Pediatr Infect Dis J (2015) 0.75
Web-Based Surveillance Systems for Human, Animal, and Plant Diseases. Microbiol Spectr (2014) 0.75